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The tumour extracellular matrix acts as a barrier to the delivery of therapeutic agents. To test the hypothesis that extracellular
matrix composition governs the penetration rate of macromolecules in tumour tissue, we measured the diffusion coefﬁcient of
nonspeciﬁc IgG in three rhabdomyosarcoma subclones growing as multicellular spheroids in vitro or as subcutaneous tumours
in dorsal windows in vivo. In subcutaneous tumours, the diffusion coefﬁcient decreased with increasing content of collagen and
sulphated glycosaminoglycans. When grown as multicellular spheroids, no differences in either extracellular matrix composition
or diffusion coefﬁcient were found. Comparison of in vitro vs in vivo results suggests an over-riding role of host stromal cells in
extracellular matrix production subjected to modulation by tumour cells. Penetration of therapeutic macromolecules through
tumour extracellular matrix might thus be largely determined by the host organ. Hence, caution must be exercised in
extrapolating drug penetrability from spheroids and multilayer cellular sandwiches consisting of only tumour cells to tumours in
vivo.
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The extracellular matrix (ECM) is a potent barrier to the delivery
and penetration of complex biopharmaceuticals such as monoclo-
nal antibodies, therapeutic proteins, or genes. Due to the
elevated interstitial ﬂuid pressure in tumours (Boucher and Jain,
1992), the therapeutic agents must reach the tumour cells by inter-
stitial diffusion. It is not clear whether the network of ﬁbrillar
collage or the glycosaminoglycan (GAG) gel plays the most impor-
tant role in limiting the diffusion of macromolecules through the
ECM, and what the role of the host stromal cells is. Netti et al
(2000) found that the amount of collagen in tumours correlated
inversely with the diffusion coefﬁcient of macromolecules, and
collagenase treatment of the tumour increased the diffusion coefﬁ-
cient. Pluen et al (2001) provided further support for the role of
collagen by measuring diffusion in tumours grown in subcutaneous
tissue and the cranium. Hyaluronidase, on the other hand, is
reported to reduce the diffusion coefﬁcient of albumin in lung
interstitium (Qiu et al, 1999).
We postulated that diffusion of macromolecules is hindered
both by the collagen network and by the hydrophilic gel of GAG
and proteoglycans. To test this hypothesis we used three distinct
clones with different degrees of differentiation and ECM (Groeschel
et al, 1994) derived from a rat rhabdomyosarcoma, growing as
multicellular spheroids in vitro or subcutaneously in dorsal
chambers in mice in vivo. The production of ECM in tumours is
the result of an active interaction between the tumour cells and
stromal cells of the host (Gullino and Grantham, 1962; Knudson
et al, 1984), whereas the extracellular matrix of multicellular spher-
oids is solely produced by the tumour cells. Comparison of the
ECM composition in tumours growing as xenografts in vivo and
as multicellular spheroids in vitro, is likely to reveal the inﬂuence
of the host stromal cells on ECM composition and transport prop-
erties.
MATERIALS AND METHODS
Spheroids
Three clonal subpopulations A, B, and C derived from the same
dimethyl-benzanthracene-induced rhabdomyosarcoma in rat
(Gerharz et al, 1988) were kindly provided by Dr H Gabbert
(Department of Pathology, University of Dusseldorf, Germany).
The cell lines were grown at 378C and 5% CO2 Dulbecco’s Modi-
ﬁed Eagle’s Medium with 4500 mg glucose ml
71, supplemented
with 10% heat-inactivated foetal calf serum and 100 U ml
71 peni-
cillin-streptomycin (all from Sigma).
Spheroids were initiated using the liquid overlay technique.
2×10
5 cells were grown for 5 days in tissue culture ﬂasks (75
cm
2) coated with 1% agarose. Approximately 20 spheroids with a
diameter less than 200 mm were placed inside 50 mm long glass
capillary tubes (Vitro Dynamics Inc, Rockaway, NJ, USA) with
sides of 0.2 mm64 mm, and cultivated for an additional day to
allow the spheroids to adhere to the surface. The medium was
removed by capillary forces, replaced with medium containing
0.3 mg ml
71 ﬂuorescein-IgG, and incubated for 4–6 h.
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Tumour cells were implanted either subcutaneously in dorsal skin-
fold chambers (Leunig et al, 1992) or injected subcutaneously in
the ﬂank of SCID mice. The transparent window chamber allowed
non-invasive diffusion measurements. When the tumours growing
in the dorsal chambers ﬁlled the chambers, 200 ml of 2 mg ml
71
ﬂuorescein-IgG was administered by tail vein injection. Clone A
grew somewhat faster than clone B and C, ﬁlling the chamber with
a tumour diameter of approximately 10 mm 6–9 days after
implantation, whereas 9–12 days were needed for clones B and
C. The tumours growing subcutaneously in the ﬂank were used
for measuring ECM constituents, as the amount of tumour tissue
from dorsal chambers was not sufﬁcient for such measurements.
Sections of parafﬁn-embedded tumours and multicellular spheroids
were stained with haematoxylin-eosin. All animal experiments have
been carried out with ethical committee approval. The ethical
guidelines that were followed meet the standards required by the
UKCCCR guidelines (Workman et al, 1998).
Diffusion measurements
Interstitial diffusion was measured by ﬂuorescence recovery after
photobleaching (FRAP), 24 h after i.v. injection of ﬂuorescein
labelled IgG, as described by Berk et al (1993; 1997). Goat g-globu-
lin (Sigma, St. Louis, MO, USA) was labelled with the ﬂuorophore
ﬂuorescein-EX using a protein labelling kit from Molecular Probes
(Eugene, OR, USA).
An argon laser (model 2020; Spectra-Physics, Mountain View,
CA, USA) at 488 nm, was focused onto the tissue through the
microscope objective (620, NA 0.4) to form a circular spot
with nominal diameter of 40 mm. After a brief exposure to laser
illumination, wide-ﬁeld epiﬂuorescence images were projected
onto an intensiﬁed CCD camera (model 2400; Hamamatsu
Photonics, Hamamatsu City, Japan), digitised, and stored at a
rate of ﬁve images s
71 for 130 s. Photobleaching recoveries
were quantiﬁed by spatial Fourier analysis (Berk et al, 1993,
1997). The diffusion coefﬁcient was given as the ratio relative
to diffusion in solution to emphasise the reduction of the diffu-
sion coefﬁcient in tissue. The use of ratio also effectively
eliminates the potential systematic error associated with the
measurement technique.
Disintegration of tissue
The tumour tissue had to be solubilised in order to measure ECM
constituents. Spheroids and tumours cut in pieces were placed in a
digest buffer (50 mg tissue ml
71). The buffer consisted of
125 mgm l
71 papain (Sigma) in 0.1 M Na-phosphate (Merck,
Darmstadt, Germany), 5 mM Na2EDTA (Merck, Darmstadt,
Germany), and 5 mM cysteine-HCl (Sigma), pH 6.0. Tumour
tissue and spheroids were ﬁnely dispersed with a homogenizer
(Polytron; Brinkmann Instrument, Westbury, NY, USA), and incu-
bated in the digest buffer for 18 h at 608C.
GAG content
The total amount of GAG was determined by the reaction of
uronic acid with carbazole as described by Bitter and Muir
(1962). Brieﬂy, 0.5 ml solubilised tissue diluted in water saturated
with benzoic acid was carefully layered onto 3 ml of sulphuric acid
at 08C, shaken, and boiled for 10 min. After cooling to room
temperature, 100 ml carbazole (Sigma) reagent was added, the
samples shaken, boiled for 15 min and cooled to room tempera-
ture. The absorbance was measured using a spectrophotometer
(model UV-1201; Shimadzu, Kyoto, Japan) at 530 nm, and the
concentration of GAG equivalent to uronic acid was determined
from the standard curve.
Sulphated glycosaminoglycans (s-GAG) was measured using the
Blyscan proteoglycan and s-GAG assay (Biocolor Ltd, Belfast,
Ireland), which is based on the speciﬁc binding of the cationic
dye, 1,9-dimethylmethylene blue (Farndale et al, 1986). Brieﬂy,
10 ml of diluted solubilised sample and 1 ml Blyscan dye reagent
was mixed for 30 min at room temperature and centrifuged for
10 min. The polysaccharide-dye complex precipitated and was
resolved in 1 ml dissociation reagent. The absorbance of bound
dye was measured at 656 nm. The concentration of s-GAG equiva-
lent to uronic acid was obtained using the standards of the Blyscan
assay with the assay for total GAG.
Concentration of hyaluronan (HA) was estimated as the differ-
ence between total GAG and s-GAG, both expressed equivalent to
uronic acid.
Collagen content
The collagen content was determined by measuring hydroxyproline
according to Woessner (1961). Brieﬂy, 300 ml of solubilised sample
was hydrolysed by adding HCl to a ﬁnal concentration of 6N. The
samples were hydrolysed at 1108C for 18 h, followed by neutralisa-
tion using 2.5 N NaOH. Hydroxyproline was oxidised by adding
chloroamine T, mixed and left at room temperature for 20 min.
Cloramine T (Sigma) was destroyed by adding 1 ml 3.15 M perclo-
ric acid (Merck, Darmstadt, Germany), mixed and left at room
temperature for 5 min. Finally, 1 ml p-dimethylaminobenzaldehyde
(Sigma) was added, mixed and placed at 608C for 20 min. The
absorbance was measured spectrophotometrically at 557 nm. The
concentration of hydroxyproline was determined from the standard
curve, and concentration of collagen estimated by assuming
6.94 mg collagen mg
71 hydroxyproline (Jackson and Cleary, 1976).
Statistical analysis
Statistical comparisons of data were performed using the one-way
analysis of variance, ANOVA. The signiﬁcance criterion of P50.05
was used. Correlation between parameters was calculated as the
Person product moment correlation coefﬁcient. Regression analysis
was done by least squares ﬁt. All statistical analysis was performed
using Minitab (Minitab Inc., State Collage, PA, USA).
RESULTS
ECM composition
The three rhabdomyosarcoma clones exhibited different ECM
composition when grown in vivo. In contrast, no difference in
any of the measured ECM constituents was observed when the cells
grew as multicellular spheroids (Figures 1 and 2). In vivo, clone C
had approximately 30% less collagen (Figure 1), and about 50%
more HA than clone A and B (Figure 2). No difference was found
in the level of total GAG. Thus, the content of s-GAG, the differ-
ence between total GAG and HA, was lower in clone C compared
to clone A and B (Figure 2). Plotting collagen vs s-GAG showed a
positive correlation, and the correlation coefﬁcient was estimated
to be 0.98 (P=0.10).
The ECM composition measured in tumours growing subcuta-
neously in the ﬂank was conﬁrmed by immunoﬂuorescence in
tumours growing in dorsal chambers. Sections of tumours were
stained using a primary antibody against collagen type I and the
immunoﬂuorescence quantiﬁed by confocal laser scanning micro-
scopy (data not shown).
Haematoxylin-eosin stained sections of parafﬁn embedded
tumours and spheroids showed a higher cell density in tumours
growing in dorsal chambers compared to spheroids (Figure 3).
In spheroids the cell density was rather heterogeneous with large
areas without cells, whereas the tumours showed a more homoge-
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clones.
Interstitial diffusion coefﬁcients
Therapeutic macromolecules must diffuse through the ECM,
consisting of a ﬁbrillar protein network embedded in a hydrophilic
gel of GAG, in order to reach the tumour cells. The diffusion coef-
ﬁcient of IgG was measured by FRAP. The ratio between the
diffusion coefﬁcient in tumours growing in dorsal windows and
the diffusion coefﬁcient in free solution varied from 0.30 to 0.50
(Figure 4). In vivo, IgG diffusion in clone C tumours was about
30 and 70% higher compared to clone A and B tumours, respec-
tively. For multicellular spheroids, no signiﬁcant differences in
the diffusion coefﬁcient of IgG were found between the three
clones, and the ratio of diffusivities was reduced to about 50%
(Figure 4).
No difference in matrix content or diffusion between the
subclones grown as spheroids
Although the tumour cells generated an extracellular matrix with
measurable collagen and GAG content when grown in vitro as
multicellular spheroids, no difference among the three clones
grown as spheroids was found with respect to collagen content
or GAG content (total GAG, HA, s-GAG). Correspondingly, there
was no difference in diffusion coefﬁcient among the three clones.
In all subclones the diffusion coefﬁcient of IgG was the same as
in clone C growing as xenograft in vivo.
Correlation between matrix content and diffusion in
tumour xenografts
In contrast to the spheroids, the tumour xenografts did exhibit
signiﬁcant differences in ECM composition and transport proper-
ties among the clones. The diffusion coefﬁcient measured in vivo
decreased with increasing concentration of collagen (r
2=0.72;
P=0.35), and s-GAG (r
2=0.86; P=0.24), and increased with
increasing concentration of HA (r
2=0.92; P=0.18). Clone C having
the lowest amount of collagen and s-GAG, and the highest
amount of HA was found to have the highest diffusion coefﬁcient
(Figure 4). These data therefore collectively suggest that IgG diffu-
sion is principally hindered by the collagen network and/or the s-
GAG.
DISCUSSION
In seeking to establish a quantitative relationship between
tumour ECM properties and the penetration of high-molecular
weight therapeutics, we examined the interstitial diffusion coef-
ﬁcient of IgG as a function of collagen, GAG, s-GAG, and
HA content. An important novel aspect was to study the
impact of host stromal cells by comparing ECM content
and diffusion in tumours growing in mice in vivo or as
spheroids in vitro.
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Figure 1 Collagen content in clone A, B, and C of BAHAN rhabdomyo-
sarcoma growing as tumours or as multicellular spheroids. Each value re-
presents the mean and standard error of 8–12 measurements of
spheroids and 10 tumours. Signiﬁcant difference between the clones is in-
dicated (*).
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Figure 2 GAG content in clone A, B, and C of BAHAN rhabdomyosar-
coma growing as tumours (upper panel) or as multicellular spheroids (low-
er panel). GAG, s-GAG and hyaluronan are all expressed as equivalent
mass to uronic acid. Each value represents the mean and standard error
of four measurements of spheroids and 12–14 tumours. Signiﬁcant differ-
ence between the clones is indicated (*).
A B
Figure 3 Haematoxylin-eosin stained sections of parafﬁn-embedded tu-
mours (A) and multicellular spheroids (B). Images were obtained using
606 oil immersion objective. Bar=30 mm.
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An inverse, but weak, correlation between collagen content and
diffusion coefﬁcient was found and is consistent with ﬁndings in
various human and murine tumours (Netti et al, 2000), as well
as in matrices in vitro (Shenoy and Rosenblatt, 1995). Increasing
the concentration of collagen supposedly decreases the distance
between neighbouring ﬁbrils, thus decreasing the pore size of the
matrix, thereby increasing the frictional interactions between the
IgG and the matrix. In accordance with this, greater diffusional
hindrance was recently demonstrated in tumours with higher levels
of collagen type I organised into ﬁbrils (Pluen et al, 2001). In the
in vivo study by Netti et al (2000), the interpretation was compli-
cated by the substantial differences in cell morphology, collagen
organisation, and the lack of knowledge about the origin of the
matrix material from tumour versus stromal cells. In the present
study using three clones isolated from the same rhabdomyosarco-
ma, it seems reasonable to assume that the collagen was
produced by host cells in response to interactions with the growing
tumour cells, and that there is less differences in matrix assembly
and organisation between these three tumour clones compared
with tumours with different origin. Our results are therefore a
signiﬁcant conﬁrmation of the correlation between collagen
content and diffusional hindrance.
Previous comparison of different human tumour xenografts did
not reveal a correlation between the diffusion coefﬁcient and s-
GAG content (Netti et al, 2000). We found an inverse, but weak,
correlation with s-GAG. In solutions of HA or sulphated proteo-
glycans, however, the diffusivity of macromolecules is reported to
decrease exponentially with increasing concentration of HA (Laur-
ent et al, 1963) or sulphated proteoglycans (Preston and Snowden,
1973). This relationship has also been explained theoretically
based on the stochastic model of diffusion (Ogston and Sherman,
1961). Thus, our results indicate that HA and s-GAG have differ-
ent effects on diffusion in complex in vivo systems compared to
in pure solution, or the discrepancy is due to the large differences
in HA and proteoglycan concentrations in the solutions compared
to tissue. The inverse correlation between diffusion and s-GAG
might be explained by reduced sulphation of GAG as the s-
GAG content decreases. Sulphation increases the charge density,
and increases the afﬁnity of GAG for collagen, ﬁbronectin and
laminin (Iozzo, 1985). The reduced afﬁnity between GAG and
the protein network of collagen and ﬁbronectin might change
the assembly and structure of the ECM thereby increasing the
pore size of the ECM. The requirement for GAG sulphation to
obtain collagen binding has also been demonstrated by Comper
and Laurent (1978) who found that collagen binds to chondroitin
sulphate, dermatan sulphate, heparan sulphate and heparin, but
not to HA or keratin. Consistent with this, we found that the
content of collagen and s-GAG correlated, which might reﬂect
that the s-GAG content is determined by the amount of collagen
available to bind it. This supports the idea of Netti et al (2000)
that the proteoglycans require a stabilising solid matrix to fully
hinder the transport through ECM, and that collagen has this
stabilising and binding capacity. Another explanation is that a
reduction in the overall negative charge density also reduces the
repulsive electrostatic forces between the GAG’s and the negatively
charged IgG, thereby increasing both the available volume and the
diffusivity (Maroudas, 1970). Further studies of diffusion in
tumours with the same collagen content, but with different s-
GAG compositions are needed to discriminate the role of s-
GAG from that of collagen.
The tumour cells growing as spheroids generated an ECM with
collagen and GAG content about 10 and two times lower than in
xenografts in vivo, respectively. Although the distribution of
collagen is different between the three clones growing as spheroids
(Groeschel et al, 1994), we found no differences in the amount of
collagen or GAG (total GAG, s-GAG, HA). Correspondingly, no
difference in diffusion coefﬁcient among the three clones was seen.
The low level of ECM constituents in spheroids, suggests a higher
diffusion coefﬁcient than in tumours. However, the diffusion coef-
ﬁcient of IgG in spheroids was the same as found for clone C
growing in the dorsal chamber. There are two possible explana-
tions for this apparent paradox: (1) Below a certain threshold
level of ECM constituents, the diffusion coefﬁcient does not
increase further, i.e. even a low content of ECM constituents
hinders molecular transport considerably, or (2) the extracellular
space and structure are radically different in tumours compared
to spheroids. The spheroids had larger areas of extracellular space
and lower cell density than the tumours. Thus, the low diffusion
coefﬁcient in spheroids was not due to compact spheroids. It is
the structure of the interstitium rather than a high cell density that
causes the hindrance. The steric exclusion and tortuosity of path-
ways through the interstitium are thus greater in the multicellular
spheroids than in the tumours. The diffusion is not solely depen-
dent on the content of ECM constituents, but the structure of
these constituents also plays a crucial role. The lack of a vascular
network in spheroids might also contribute to the difference in
ECM structure.
Indirect inﬂuence of stromal cells on the transport
parameters
The ECM constituents in tumours are normally produced by the
stromal cells of the host, whereas the tumour cells may modulate
the synthesis rate to ensure a favourable environment for the
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Figure 4 Diffusion coefﬁcient D of IgG in BAHAN rhabdomyosarcoma growing as tumours (closed symbols) or as multicellular spheroids (open symbols)
relative to D0 in solution. Clones A, B, and C are represented by (*/*), (&/&), and (~/~), respectively. D/D0 is plotted as a function of collagen (i), s-
GAG (ii), and hyaluronan (iii). s-GAG and hyaluronan are expressed as equivalent mass to uronic acid. Each value of D represents the mean and standard
error of 4–7 tumours or spheroids with 5–12 FRAP measurements per tumour or spheroid.
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esis rate either directly or indirectly by releasing cytokines.
However, it has been reported that tumour cells, and especially
sarcoma cells might have the capacity to synthesise the ECM
constituents themselves. Tumour cells growing as three-dimen-
sional multicellular spheroids possess this capacity. Multicellular
spheroids being an in vitro system of intermediate complexity
between monolayer cultures and tumours may contain an ECM
at an intermediate level (Davies et al, 1997). Consistent with this,
we also found less collagen and GAG in the spheroids compared
to the tumours.
The difference in ECM content of tumours observed when
growing as xenografts in vivo was not maintained when the
tumours cells were grown in vitro. This indicates that the stromal
cells themselves or the interaction between the stromal cells and
the tumour cells play an important role in inducing the difference
in ECM composition and as a consequence inﬂuence molecular
transport. This is consistent with the slower diffusion of various
macromolecules found in tumours growing in dorsal chambers
compared with cranial windows. The slower diffusion in dorsal
chambers was associated with a higher density of stromal cells
and higher level of collagen type I organised into ﬁbrils (Pluen et
al, 2001). The use of multicellular spheroids or multilayer cellular
sandwiches incorporating normal ﬁbroblasts might thus be a more
accurate tumour model than spheroids containing only tumour
cells. The importance of the tissue structure and microenvironment
has also been reported by Bissell et al (1999) who reported that the
structure of the tissue is dominant over the genome due to the
bidirectional pathways that connect the cellular microenvironment
and the genome.
Clinical implications
In the design of macromolecule-based therapies, ranging from
protein-based to gene therapy, the macromolecules must be able
to penetrate through tumour tissue. It would appear overly
simplistic to assume a single value for penetration resistance in
all tumours. The present work, taken together with other recent
studies (Netti et al, 2000; Pluen et al, 2001), begins to provide a
rationale for assessing the relative penetrability of different tumours
depending on the tumour type and the site of growth. This work
again implicates the collage network and collagen-binding GAGs
as factors in hindering the interstitial diffusion of macromolecules.
Multicellular spheroids and multilayer cellular sandwiches/
membranes are being used to test the penetrability and effective-
ness of therapeutics (Fracasso and Colombatti, 2000; Padron et
al, 2000; Johnson et al, 2001). Since these in vitro systems do
not have the host stromal cells, the present work shows that
caution must be exercised in extrapolating the results obtained
from these systems to tumours in vivo.
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